Global COPD Burden; Driving Restrictions After Fainting? Also in TTHealthWatch: best meds for insomnia and the effect of calorie labels in supermarkets Aug 06, 2022 podcast
First Treatment Approved for Eosinophilic Esophagitis FDA expands dupilumab's label to treat inflammatory condition May 20, 2022
Five Core Principles to Empower Our Patients Even through virtual care, promoting self-efficacy can lead to lasting behavior change May 20, 2022
For Young Adults, Fewer Burgers May Mean Healthier Lungs Later On "Healthy diet" in youth tied to lower mid-life emphysema risk May 20, 2022
Vulnerable Teens May Ask, Who'll Stop the Rain? Precipitation seen as trigger for airway inflammation May 19, 2022
Triple Therapy for COPD: One Drug Too Many, Too Often? Dropping the inhaled steroid seems to help many patients in real-world study May 19, 2022
Here's What Happened to Asthma, COPD Admissions After a Big Polluter Shut Down Correlation bolsters evidence that environmental air quality can be modified to good effect May 18, 2022
Two Drugs Better Than One for 'Rescue' Asthma Therapy Fixed-dose combo inhaler beats good old albuterol May 15, 2022
Pumping (IV) Iron Linked to Varying Anaphylaxis Risk for Older Adults Study finds risk was low, but unequal across different products Mar 28, 2022
Nasal Spray Flu Vaccine No Problem for Kids With Asthma Contrary to CDC guidance, nasal spray did not increase asthma exacerbations Mar 28, 2022
Military Exposure to Burn Pits Under Scrutiny Wearable technology, better registries, "compassionate common sense" urged over denials of harm Mar 17, 2022
Antisense Drug Slashed Hereditary Angioedema Attacks in Small Study Donidalorsen also allowed longer intervals between treatments Mar 16, 2022
First Generic OK'd for Popular Asthma, COPD Inhaler FDA approves Mylan's Symbicort copy, reflecting agency's commitment to "increase competition" Mar 15, 2022
First Drug-Eluting Contact Lens Wins FDA Nod Contact lens releases antihistamine to treat itchy eyes Mar 03, 2022
Mepolizumab Reduces Need for Oral Steroids in Severe Asthma Some adults on the IL-5 antibody were able to stop taking systemic steroids Mar 02, 2022
Docs Debate Home Spirometry Is it ready for prime time or is it just a toy with possible serious consequences? Mar 02, 2022
Does One Mab Come Out on Top for Boosting Lung Function in Asthma? Dupilumab edges out other biologics, but differences were small in indirection comparison Mar 01, 2022
Mepolizumab Cuts Asthma Flare-Ups in Disadvantaged Kids Black and Hispanic children living in urban settings benefited from biologic therapy Mar 01, 2022
Many Severe Asthma Patients Achieve Remission on Biologics Year-long freedom from exacerbations without steroids reported in real-world study Feb 28, 2022
Tezepelumab Benefits Asthma Patients Year-Round Biologic consistently reduced the annualized asthma exacerbation rate Feb 28, 2022
Medical Approach May Work in Nasal Polyps With Asthma Omalizumab improves polyp symptom scores with low recurrence rate Feb 28, 2022
Glimpses of Hope for Lebrikizumab in Asthma Subgroup targeting may hold promise for biologic Feb 28, 2022
One Nutty Gene: Peanut Oral Immunotherapy Outcomes Affected by HLA Allele Carriers of immune system gene variant show better response to treatment Feb 28, 2022
Dupilumab Continues to Show Promise in Eosinophilic Esophagitis Almost 60% of patients in LIBERTY EoE TREET study achieved remission Feb 27, 2022
Black, Latinx Adults With Asthma Benefit From Inhaled Glucocorticoid Add-On "Shovel-ready" intervention can help reduce disparities in asthma burden, researchers say Feb 26, 2022
10 ֱ With the Lowest Hourly Rate Calculated by annual salary divided by number of hours worked Feb 23, 2022
Can Switching Inhalers Reduce Your Carbon Footprint? DPIs and pMDIs both effective for asthma control, but only one may help the earth Feb 08, 2022
Oral Peanut Allergy Tx May Be Even More Effective in Younger Children Earlier oral immunotherapy "ready for immediate real-world implementation," editorialists argue Jan 20, 2022
FDA OKs First-in-Class Biologic for Severe Asthma Tezspire is first biologic for this condition with no phenotype or biomarker limitations Dec 20, 2021
Efforts Needed to De-Escalate Use of Inhaled Corticosteroids in COPD Clinicians are not always following the guidelines Dec 06, 2021
Are Second COVID Vax Doses Too Risky After Allergic Reaction to the First? Mostly no, says military doctor Nov 10, 2021
HAE Still Drawing Attention From Drugmakers Two new products show midstage promise in hereditary angioedema Nov 10, 2021
For Some Food-Allergic Kids (and Parents), Anaphylaxis Isn't the Worst Problem It's the unnecessary, crippling worry about the possibility of it Nov 08, 2021
Peanut Allergy Patch Still Looks Good 3 Years Later Reactions diminish over time in open-label study Nov 07, 2021
Guidance on Exposing Babies Early to Peanuts Not Catching On Parents say their docs didn't make a point of recommending it Nov 07, 2021
Could This Biologic Drug Work in Patients Lacking Its Target? Bizarre finding with omalizumab Nov 07, 2021
Mixed Results With Anti-Interleukin Biologics in Asthma One shows promise; another fails miserably (and mysteriously) Oct 27, 2021
Ho-Hum Oral Presentations on COPD Turn Into Fascinating Roundtable Here's why online meetings can be great Oct 22, 2021
Azithromycin Use Tied to Fewer Exacerbations in Asthma Patients Prophylactic benefits observed in real-world study Oct 20, 2021